Zolbetuximab & Nivolumab: CLDN18.2+ Gastric Cancer Trial

Promising Drug Combination Shows Efficacy in Advanced Gastric Cancer In a significant development for patients battling advanced gastric cancer, a novel treatment approach combining zolbetuximab, mFOLFOX6 chemotherapy, and nivolumab has demonstrated encouraging results in a recent clinical trial. The findings, stemming from cohort 4 of the ILUSTRO study, offer renewed hope for individuals with CLDN18.2-positive, … Read more

Melanoma: 5-Year Survival with Ipi & Nivo Therapy

Melanoma Breakthrough: Five-Year Data Shows High Survival Rates with Novel Immunotherapy Approach Groundbreaking five-year follow-up data reveals remarkably positive outcomes for patients with high-risk stage III melanoma treated with a combination of immunotherapy drugs, followed by surgery and additional therapy tailored to their response. The findings, stemming from the PRADO extension cohort of the OpACIN-neo … Read more

Liquid Biopsies: Cancer Care & Early Detection

Liquid Biopsies: A Revolution in Cancer Detection and Treatment New York, NY – A paradigm shift is underway in the fight against cancer. Researchers are increasingly focused on harnessing the power of “liquid biopsies” – analyzing circulating tumor cells (CTCs) and tumor DNA (ctDNA) found in blood samples – to revolutionize how the disease is … Read more